NCCN Clinical Practice Guidelines in Oncology Symposium™ Colon and Rectal Cancers
WHEN: Friday, November 06, 2009 (Baltimore, Maryland)
WHERE: Sheraton Baltimore City Center Hotel
101 West Fayette Street
NCCN, drawing on the expertise of faculty from its 21 Member Institutions, has developed and maintains clinical practice guidelines addressing colon and rectal cancers as part of its complete library of NCCN Clinical Practice Guidelines in Oncology™.
The NCCN Colon and Rectal Cancers Guidelines provide sequential recommendations for the management of lower G.I. malignancies. The symposium topics include surgical approaches to colorectal cancers, adjuvant therapy for locoregional rectal cancer, therapy for advanced disease and a review of ongoing studies, and the NCCN Outcomes Database: Colorectal Cancer.
Using the NCCN Guidelines as a resource, this half-day program will address the topics listed above and feature interactive audience participation via case scenarios. An audience response system will be utilized to illustrate the application of the guidelines and the rationales for specific recommendations.
Following this program, participants should be able to:
Describe the role of NCCN colon and rectal cancers outcomes database in benchmarking quality of care;
List the different surgical approaches to management of colon cancer based on site and stage at presentation;
Define rectal cancer and describe surgical treatment options available; State the role of pre- and postoperative radiation in combination with chemotherapy in the management of rectal cancer; Summarize the principles of pre and post-operative therapy for rectal cancer as described in the NCCN Clinical Practice Guidelines in Oncology™
Describe the chemotherapies available for metastatic colon cancer as stated in the NCCN Clinical Practice Guidelines in Oncology™; Summarize data presented regarding ongoing trials in metastatic colorectal cancer.
This educational program is designed to meet the needs of oncologists, nurses, pharmacists, and other healthcare professionals who manage patients with cancer.
There is no fee for this educational activity. In order to receive a statement of credit, participants will need to attend the educational activity and complete the evaluation form. Partial credit will not be awarded. Statements of credit will be mailed within 4 to 6 weeks of the meeting. Pharmacists should note that they must attend the entire activity to be eligible for credit.
This is a knowledge-based educational activity.
All faculty participating in NCCN continuing education activities are expected to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME’s and ANCC’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2 and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.
Supported by educational grants from Amgen, Bristol-Myers Squibb Company and ImClone Systems Incorporated, Genentech BioOncology, Pfizer Inc., and sanofi-aventis, U.S.
Registration fees are:
Nurses, Physicians, Pharmacists, and Other Health Care Professionals No Charge
Non-Supporting Industry $495.00
Supporting Industry No Charge
If cancellation is necessary, please notify NCCN. A substitute attendee may be sent in your place. Registration fees are non-refundable.
Register now to secure a seat at this symposium.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins